These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project. Klepp O; Olsson AM; Ous S; Nilsson S; Høisaether PA; Tveter K Scand J Urol Nephrol; 1991; 25(3):179-90. PubMed ID: 1658924 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group. Klepp O; Olsson AM; Henrikson H; Aass N; Dahl O; Stenwig AE; Persson BE; Cavallin-Ståhl E; Fosså SD; Wahlqvist L J Clin Oncol; 1990 Mar; 8(3):509-18. PubMed ID: 1689773 [TBL] [Abstract][Full Text] [Related]
4. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein. Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428 [TBL] [Abstract][Full Text] [Related]
5. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases. Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381 [TBL] [Abstract][Full Text] [Related]
6. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA). Klepp O; Flodgren P; Maartman-Moe H; Lindholm CE; Unsgaard B; Teigum H; Fosså SD; Paus E Ann Oncol; 1990 Jul; 1(4):281-8. PubMed ID: 1702312 [TBL] [Abstract][Full Text] [Related]
7. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. Amato RJ; Ro JY; Ayala AG; Swanson DA Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368 [TBL] [Abstract][Full Text] [Related]
8. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only. Ondrus D; Ondrusova M; Hornak M; Matoska J Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374 [TBL] [Abstract][Full Text] [Related]
9. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis. Guney S; Guney N; Sonmez NC; Ergenekon E Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067 [TBL] [Abstract][Full Text] [Related]
10. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse. Alexandre J; Fizazi K; Mahé C; Culine S; Droz JP; Théodore C; Terrier-Lacombe MJ Eur J Cancer; 2001 Mar; 37(5):576-82. PubMed ID: 11290432 [TBL] [Abstract][Full Text] [Related]
11. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein. Peterson M; Beck S; Bihrle R; Einhorn L; Foster R BJU Int; 2009 Jul; 104(2):176-8. PubMed ID: 19493258 [TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal histologic findings of patients with elevated serum alpha-fetoprotein and pure seminoma at orchiectomy. Kundu SD; Carver BS; Sheinfeld J Urology; 2011 Oct; 78(4):844-7. PubMed ID: 21782217 [TBL] [Abstract][Full Text] [Related]
13. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature. Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors]. Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998 [TBL] [Abstract][Full Text] [Related]
15. Observations after orchiectomy in clinical stage I nonseminomatous germ cell tumors of the testis. Kuo JY; Chin T; Hsieh YL; Lin AT; Chang YH; Wei C; Chen KK; Chang LS Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):356-61. PubMed ID: 10389293 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors. Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752 [TBL] [Abstract][Full Text] [Related]
17. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003]. Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676 [TBL] [Abstract][Full Text] [Related]
19. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours. Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R; Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368 [TBL] [Abstract][Full Text] [Related]
20. An unusual late relapse in pathologic stage I non-seminomatous germ cell tumor: case report and review of the literature. Bilgrami S; Chen L; Shafi N; Synnott V; Greenberg B Urol Int; 1994; 53(3):176-8. PubMed ID: 7544042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]